Detected ·
Remepy
$36M—
Remepy raised $36M in Series A to advance their "Hybrid Drugs" vision, combining prescription medicines with personalized, AI-driven therapeutic applications. Investors include M Ventures, NFX, Vine Ventures, Qumra Capital, and others.
- Website
- www.remepy.com
- linkedin.com/company/remepy
- Amount
- $36 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-08-13 08:03:41 UTC
- Signal ID
- 7ae6788c-2c45-40db-8642-e5c16dd8e58d
As the API returns it
{
"id": "7ae6788c-2c45-40db-8642-e5c16dd8e58d",
"created_at": "2026-08-13T08:03:41.198192Z",
"company_name": "Remepy",
"company_website_url": "www.remepy.com",
"company_linkedin_url": "https://www.linkedin.com/company/remepy",
"event_type": "funding",
"funding_amount": 36000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Remepy raised $36M in Series A to advance their \"Hybrid Drugs\" vision, combining prescription medicines with personalized, AI-driven therapeutic applications. Investors include M Ventures, NFX, Vine Ventures, Qumra Capital, and others.*"
}